BARINTHUS BIOTHERAPEUTICS PLC — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-26.1% -$3M
$-15M
Free Cash Flow↓-100.0% -$13M
$0
Investing Cash Flow
$2K
Financing Cash Flow↓-100.0% -$837K
$0
Capex↓-100.0% -$278K
$0
Stock-Based Comp↓-7.8% -$59K
$696K
D&A↓-36.3% -$519K
$909K
SBC Allocated Expense↓-7.8% -$59K
$696K